Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer.
dos Reis ST, Villanova FE, Andrade PM, Pontes J Jr, de Sousa-Canavez JM, Sañudo A, Antunes AA, Dall'oglio MF, Srougi M, Moreira Leite KR.
dos Reis ST, et al. Among authors: villanova fe.
Urol Oncol. 2010 Nov-Dec;28(6):624-7. doi: 10.1016/j.urolonc.2008.10.012. Epub 2008 Dec 30.
Urol Oncol. 2010.
PMID: 19117773